Crucell N.V. (ADR) (CRXL)

CAPS Rating:

A fully integrated biopharmaceutical company, focuses on developing, producing and marketing vaccines and antibodies against infectious diseases for private and public markets worldwide and leverage its novel, proprietary technologies.